Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

NRXPNRXP
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in NRX PHARMACEUTICALS INC

Yes. Citadel Advisors holds 680,043 shares of NRXP (NRX Pharmaceuticals), worth $2.8M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$2.8M

Current Shares

680,043

Total Value Change

+$2.5M

Total Shares Change

+587,682

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
680,043
-
$2.8M0.0%$4.09
36
2025-Q3
Exited
0
-100.0%
$00.0%$3.25
0
2025-Q2
New
92,361
-
$301,0970.0%$3.42
32

Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used